Metamark, Hologic Collaborate on Prostate Cancer
The Progensa prostate cancer antigen 3 assay can help improve prediction of repeat biopsy outcomes in men who have had one or more prior negative prostate biopsies.
Read MoreSearch Results for: genetic testing
Emerging Infectious Diseases
In recent years, populations in a number of regions throughout the world have found themselves at ground zero for an increasing variety of previously unknown infectious and zoonotic diseases.
Read More
Molecular Diagnostic Provides Rapid Identification of New Superbug
Nanosphere reports that its FDA-cleared Verigene Gram-negative blood culture test can identify the antibiotic resistance gene associated with the emerging “phantom menace” superbug.
Read More
San Antonio Presenters Offer New Data on Genomic Diagnostics
At the 2015 San Antonio Breast Cancer Symposium, held last December in San Antonio, Texas, basic researchers and clinicians shared state-of-the art information on breast cancer research.
Read More
January 2016 Product Spotlight: Emerging Technologies Showcase
Featured emerging technologies include a portable DNA sequencing tool, a BICD2 protein marker, a blood culture assay kit, and a handheld DNA amplification system.
Read More